chr19-13453138-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001127222.2(CACNA1A):​c.400-123G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.102 in 909,456 control chromosomes in the GnomAD database, including 6,238 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1539 hom., cov: 32)
Exomes 𝑓: 0.097 ( 4699 hom. )

Consequence

CACNA1A
NM_001127222.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.115

Publications

2 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 19-13453138-C-A is Benign according to our data. Variant chr19-13453138-C-A is described in ClinVar as Benign. ClinVar VariationId is 680137.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.249 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ANM_001127222.2 linkc.400-123G>T intron_variant Intron 2 of 46 ENST00000360228.11 NP_001120694.1 O00555-8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1AENST00000360228.11 linkc.400-123G>T intron_variant Intron 2 of 46 1 NM_001127222.2 ENSP00000353362.5 O00555-8
CACNA1AENST00000638029.1 linkc.400-123G>T intron_variant Intron 2 of 47 5 ENSP00000489829.1 A0A087WW63
CACNA1AENST00000573710.7 linkc.400-123G>T intron_variant Intron 2 of 46 5 ENSP00000460092.3 A0A1C7CYY9
CACNA1AENST00000635727.1 linkc.400-123G>T intron_variant Intron 2 of 46 5 ENSP00000490001.1 A0A1B0GU81
CACNA1AENST00000637769.1 linkc.400-123G>T intron_variant Intron 2 of 46 1 ENSP00000489778.1 A0A1B0GTN7
CACNA1AENST00000636012.1 linkc.400-123G>T intron_variant Intron 2 of 45 5 ENSP00000490223.1 A0A1B0GUS3
CACNA1AENST00000637736.1 linkc.259-123G>T intron_variant Intron 1 of 45 5 ENSP00000489861.1 A0A1B0GTW2
CACNA1AENST00000636389.1 linkc.400-123G>T intron_variant Intron 2 of 46 5 ENSP00000489992.1 A0A1B0GU74
CACNA1AENST00000637432.1 linkc.400-123G>T intron_variant Intron 2 of 47 5 ENSP00000490617.1 O00555-2
CACNA1AENST00000636549.1 linkc.400-123G>T intron_variant Intron 2 of 47 5 ENSP00000490578.1 B5TYJ1
CACNA1AENST00000637927.1 linkc.400-123G>T intron_variant Intron 2 of 46 5 ENSP00000489715.1 A0A1B0GTI4
CACNA1AENST00000635895.1 linkc.400-123G>T intron_variant Intron 2 of 46 5 ENSP00000490323.1 A0A384DVW2
CACNA1AENST00000638009.2 linkc.400-123G>T intron_variant Intron 2 of 46 1 ENSP00000489913.1 O00555-3
CACNA1AENST00000637276.1 linkc.400-123G>T intron_variant Intron 2 of 45 5 ENSP00000489777.1 O00555-5
CACNA1AENST00000636768.2 linkn.400-123G>T intron_variant Intron 2 of 44 5 ENSP00000490190.2 A0A1B0GUP3
CACNA1AENST00000713789.1 linkn.400-123G>T intron_variant Intron 2 of 46 ENSP00000519091.1

Frequencies

GnomAD3 genomes
AF:
0.126
AC:
19175
AN:
151986
Hom.:
1535
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.207
Gnomad AMI
AF:
0.0121
Gnomad AMR
AF:
0.117
Gnomad ASJ
AF:
0.0528
Gnomad EAS
AF:
0.261
Gnomad SAS
AF:
0.187
Gnomad FIN
AF:
0.117
Gnomad MID
AF:
0.0791
Gnomad NFE
AF:
0.0722
Gnomad OTH
AF:
0.101
GnomAD4 exome
AF:
0.0967
AC:
73233
AN:
757352
Hom.:
4699
AF XY:
0.0985
AC XY:
38456
AN XY:
390552
show subpopulations
African (AFR)
AF:
0.208
AC:
3987
AN:
19212
American (AMR)
AF:
0.124
AC:
3560
AN:
28754
Ashkenazi Jewish (ASJ)
AF:
0.0581
AC:
984
AN:
16934
East Asian (EAS)
AF:
0.251
AC:
8752
AN:
34832
South Asian (SAS)
AF:
0.179
AC:
10118
AN:
56412
European-Finnish (FIN)
AF:
0.107
AC:
4805
AN:
44990
Middle Eastern (MID)
AF:
0.0610
AC:
228
AN:
3738
European-Non Finnish (NFE)
AF:
0.0719
AC:
37134
AN:
516188
Other (OTH)
AF:
0.101
AC:
3665
AN:
36292
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
3055
6110
9164
12219
15274
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1164
2328
3492
4656
5820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.126
AC:
19205
AN:
152104
Hom.:
1539
Cov.:
32
AF XY:
0.130
AC XY:
9670
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.207
AC:
8581
AN:
41468
American (AMR)
AF:
0.118
AC:
1801
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.0528
AC:
183
AN:
3468
East Asian (EAS)
AF:
0.261
AC:
1345
AN:
5156
South Asian (SAS)
AF:
0.186
AC:
898
AN:
4818
European-Finnish (FIN)
AF:
0.117
AC:
1237
AN:
10596
Middle Eastern (MID)
AF:
0.0816
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
0.0722
AC:
4911
AN:
68006
Other (OTH)
AF:
0.101
AC:
214
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
819
1637
2456
3274
4093
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
220
440
660
880
1100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0889
Hom.:
2488
Bravo
AF:
0.127
Asia WGS
AF:
0.211
AC:
732
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
3.8
DANN
Benign
0.77
PhyloP100
-0.12
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3764615; hg19: chr19-13563952; COSMIC: COSV64192882; API